Growth Metrics

CV Sciences (CVSI) Asset Writedowns and Impairment (2016 - 2020)

CV Sciences' Asset Writedowns and Impairment history spans 7 years, with the latest figure at $6.2 million for Q4 2020.

  • On a quarterly basis, Asset Writedowns and Impairment rose 3031.31% to $6.2 million in Q4 2020 year-over-year; TTM through Dec 2020 was $6.4 million, a 2633.05% increase, with the full-year FY2023 number at $251000.0, down 79.66% from a year prior.
  • Asset Writedowns and Impairment hit $6.2 million in Q4 2020 for CV Sciences, up from $46000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for CVSI hit a ceiling of $6.2 million in Q4 2020 and a floor of -$1000.0 in Q2 2018.
  • Historically, Asset Writedowns and Impairment has averaged $811041.7 across 5 years, with a median of $40223.0 in 2018.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 100.25% in 2018 and later skyrocketed 9800.0% in 2019.
  • Tracing CVSI's Asset Writedowns and Impairment over 5 years: stood at $3.5 million in 2016, then plummeted by 97.64% to $82565.0 in 2017, then tumbled by 97.58% to $2000.0 in 2018, then skyrocketed by 9800.0% to $198000.0 in 2019, then surged by 3031.31% to $6.2 million in 2020.
  • Business Quant data shows Asset Writedowns and Impairment for CVSI at $6.2 million in Q4 2020, $46000.0 in Q1 2020, and $198000.0 in Q4 2019.